Skip to main content
. 2015 May 19;80(2):235–241. doi: 10.1111/bcp.12616

Figure 4.

Figure 4

Kaplan–Meier analysis of (A) time to clinical worsening and (B) time to all-cause mortality by serum creatinine (sCr) status from baseline to week 12; (C) time to clinical worsening and (D) time to all-cause mortality by change in estimated glomerular filtration rate (eGFR) status from baseline to week 12. A–B Inline graphic, patients with no change or improvement in sCr; Inline graphic, patients with worsening sCr. C–D Inline graphic, patients with no change or improvement in eGFR; Inline graphic, patients with worsening eGFR.